In addition, LCP inhibited intestinal cancer cell proliferation and metastasis by inhibiting B-cell lymphoma-extra-large (Bcl-xL) and cyclin B expression and epithelial–mesenchymal transition (EMT) [21]. This evidence concerns the gene BCL2L1 and intestinal cancer.